| Title |
A randomized, placebo-controlled, double-blind study to confirm the reversal of hepatorenal syndrome type 1 with terlipressin: the REVERSE trial design
|
|---|---|
| Published in |
Open Access Journal of Clinical Trials, July 2012
|
| DOI | 10.2147/oajct.s31844 |
| Authors |
Khuramm Jamil, Boyer, Medicis, Potenziano, Pappas |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 3% |
| Unknown | 37 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 13% |
| Student > Ph. D. Student | 5 | 13% |
| Other | 5 | 13% |
| Student > Postgraduate | 4 | 11% |
| Student > Doctoral Student | 3 | 8% |
| Other | 8 | 21% |
| Unknown | 8 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 26% |
| Agricultural and Biological Sciences | 4 | 11% |
| Nursing and Health Professions | 3 | 8% |
| Social Sciences | 3 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Other | 6 | 16% |
| Unknown | 10 | 26% |